Publication | Open Access

The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-κB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats

InflammationRheumatologyAdjuvant-induced Arthritis RatsAnti-inflammatoryRheumatoid DisorderAutoimmune DiseaseMedicineRheumatic DiseasesImmunologyChronic InflammationInflammatory Rheumatic DiseaseRheumatoid Arthritis PatientsPharmacologyInflammatory DiseaseCell SignalingInflammatory ArthritisRheumatoid ArthritisMolecular Signaling